aluminum hydroxide 6.33 MG/ML
RxNorm concept 331000, clinical drug component (scdc).
- RxCUI
- 331000
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/331000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension (SCD, constitutes)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Acid Gone] (SBD, constitutes)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon] (SBD, constitutes)
- aluminum hydroxide (IN, has ingredient)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Acid Gone] (SBDC, has tradename)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 331000 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/331000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 331000. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.